In our previous study, we found that ArhGAP30 (Rho GTPase activating protein 30) functioned as a tumor-suppressor gene in CRC by promoting the acetylation and functional activation of p53 [11], however, the mechanism of ArhGAP30 inactivation in CRC remained unknown. The gene discussed is ARHGAP30; the disease is neoplasm.